Andrew Saunders
Chief Tech/Sci/R&D Officer at CellCentric Ltd.
Profile
Andrew Saunders is currently the Chief Medical Officer at CellCentric Ltd.
He previously worked as the Managing Director at Linden Oncology Ltd.
and as the Chief Medical Officer at Bioenvision, Inc. and Lytix Biopharma AS.
He also served as the Co-Chief Medical Officer at Redx Pharma Plc from 2018 to 2021.
Dr. Saunders earned a doctorate degree from Trinity College Dublin in 1989.
Andrew Saunders active positions
| Companies | Position | Start |
|---|---|---|
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Former positions of Andrew Saunders
| Companies | Position | End |
|---|---|---|
| REDX PHARMA PLC | Chief Tech/Sci/R&D Officer | 2021-02-28 |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 2007-04-08 |
| Linden Oncology Ltd. | Chief Executive Officer | - |
| LYTIX BIOPHARMA | Chief Tech/Sci/R&D Officer | - |
Training of Andrew Saunders
| Trinity College Dublin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| REDX PHARMA PLC | Health Technology |
| Private companies | 3 |
|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Linden Oncology Ltd. |
- Stock Market
- Insiders
- Andrew Saunders